{"id":44948,"date":"2021-12-08T12:00:19","date_gmt":"2021-12-08T12:00:19","guid":{"rendered":"https:\/\/new.igihe.com\/covid-19-rwanda-hits-30-vaccination-target\/"},"modified":"2021-12-10T13:55:10","modified_gmt":"2021-12-10T13:55:10","slug":"covid-19-rwanda-hits-30-vaccination-target","status":"publish","type":"post","link":"https:\/\/new.igihe.com\/english\/covid-19-rwanda-hits-30-vaccination-target\/","title":{"rendered":"COVID-19: Rwanda hits 30% vaccination target"},"content":{"rendered":"<p>The development was announced by the Minister of Health, Dr. Daniel Ngamije on Wednesday 8th December 2021 via Twitter handle.  <\/p>\n<p>\u201cToday, Rwanda achieves its Covid-19 vaccination target of covering 30% of the total population with 2 doses by the end of 2021. The objective is 70% by December 2022 (Latest!). This milestone is highly attributed to Leadership, Partnership, Coordination and Community engagement,\u201d he revealed.  <\/p>\n<p>Prime Minister, Dr. Edouard Ngirente recently told parliamentarians that Rwanda has so far administered COVID-19 vaccine doses to 6,065,691 (46%) of the total population including recipients of one dose.  <\/p>\n<p>Among others, he revealed that the country has received 12,900,760 COVID-19 vaccine doses since the inoculation program was rolled out countrywide in March 2021. <\/p>\n<p>Premier Ngirente said that the number of COVID-19 vaccine recipients are expected to reach 9,063,245 next year, following the country\u2019s commitment to start administering vaccines to people in the age bracket between 12 and 17. <\/p>\n<p>\u201cAll these people will have been vaccinated by December 2022 but we might hit the number before in consideration of expended efforts,\u201d he revealed.<\/p>\n<p>In Kigali City alone, more than 869,000 dwellers (89.2%) aged 12 and above have received two doses of COVID-19 vaccine while 1,032,499 have received the first dose.<\/p>\n<p>The vaccination efforts in the remaining parts of the country have seen 2,755,727 (34%) people fully vaccinated while 62% have received the first dose of COVID-19.<\/p>\n<p>Rwanda has been administering eight types of COVID-19 vaccines. As at 2nd December 2021, the country had received 12,900,760 doses that can be used to vaccinate 6,736,220 people excluding the booster dose.<\/p>\n<p>Rwanda received the doses through COVAX, a global initiative aimed at ensuring equitable distribution of vaccines, direct purchases while others were donated by partner countries.<\/p>\n<figure class=\"spip-document spip-document-40317 aligncenter\"><img decoding=\"async\" src=\"https:\/\/en-images.igihe.com\/jpg\/inkingo-5jpgdcfd-35f0d.jpg\" alt=\"Rwanda has hit 30% target in COVID-19 vaccination drive.  \" \/><\/figure>\n","protected":false},"excerpt":{"rendered":"<p>{Rwanda has hit the target of administering two doses of COVID-19 to 30 percent of its population giving optimism to cover 70% by the end of 2022.}  <\/p>\n","protected":false},"author":62,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[6],"tags":[72,75],"byline":[170],"hashtag":[],"class_list":["post-44948","post","type-post","status-publish","format-standard","hentry","category-news","tag-featured-news-home","tag-homenews","byline-igihe"],"bylines":[{"id":170,"name":"IGIHE","slug":"igihe","description":"","image":{"id":0,"url":"https:\/\/secure.gravatar.com\/avatar\/?s=96&d=mm&f=y&r=g","alt":"Default avatar","title":"Default avatar","caption":"","mime_type":"image\/jpeg","sizes":[]},"user_id":8}],"contributors":[{"id":170,"name":"IGIHE","slug":"igihe","description":"","image":{"id":0,"url":"https:\/\/secure.gravatar.com\/avatar\/?s=96&d=mm&f=y&r=g","alt":"Default avatar","title":"Default avatar","caption":"","mime_type":"image\/jpeg","sizes":[]},"user_id":8}],"featured_image":null,"_links":{"self":[{"href":"https:\/\/new.igihe.com\/english\/wp-json\/wp\/v2\/posts\/44948","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/new.igihe.com\/english\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/new.igihe.com\/english\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/new.igihe.com\/english\/wp-json\/wp\/v2\/users\/62"}],"replies":[{"embeddable":true,"href":"https:\/\/new.igihe.com\/english\/wp-json\/wp\/v2\/comments?post=44948"}],"version-history":[{"count":0,"href":"https:\/\/new.igihe.com\/english\/wp-json\/wp\/v2\/posts\/44948\/revisions"}],"wp:attachment":[{"href":"https:\/\/new.igihe.com\/english\/wp-json\/wp\/v2\/media?parent=44948"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/new.igihe.com\/english\/wp-json\/wp\/v2\/categories?post=44948"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/new.igihe.com\/english\/wp-json\/wp\/v2\/tags?post=44948"},{"taxonomy":"byline","embeddable":true,"href":"https:\/\/new.igihe.com\/english\/wp-json\/wp\/v2\/byline?post=44948"},{"taxonomy":"hashtag","embeddable":true,"href":"https:\/\/new.igihe.com\/english\/wp-json\/wp\/v2\/hashtag?post=44948"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}